In this podcast series Dr. Rishi Singh will be talking with: Dr. Andrew Moshfeghi on Current Insights into Anti-VEGF use in Diabetic Retinopathy; Dr. Dilsher Dhoot on how to address the treatment burden in nAMD as a provider; Dr. Ted Leng on how to address the treatment burden in nAMD with patients; Dr. Nathan Steinle on real world applications for dosing strategies in nAMD; Dr. Nancy Holekamp on drug delivery in neovascular retinal disease; and with Dr. Arshad Khanani on targeting treatment in neovascular retinal disease We encourage you to take 12 to 15 minutes out of your day to hear these updates on neovascular retinal diseases